» Articles » PMID: 8475120

Dystrophin Protects the Sarcolemma from Stresses Developed During Muscle Contraction

Overview
Specialty Science
Date 1993 Apr 15
PMID 8475120
Citations 615
Authors
Affiliations
Soon will be listed here.
Abstract

The protein dystrophin, normally found on the cytoplasmic surface of skeletal muscle cell membranes, is absent in patients with Duchenne muscular dystrophy as well as mdx (X-linked muscular dystrophy) mice. Although its primary structure has been determined, the precise functional role of dystrophin remains the subject of speculation. In the present study, we demonstrate that dystrophin-deficient muscle fibers of the mdx mouse exhibit an increased susceptibility to contraction-induced sarcolemmal rupture. The level of sarcolemmal damage is directly correlated with the magnitude of mechanical stress placed upon the membrane during contraction rather than the number of activations of the muscle. These findings strongly support the proposition that the primary function of dystrophin is to provide mechanical reinforcement to the sarcolemma and thereby protect it from the membrane stresses developed during muscle contraction. Furthermore, the methodology used in this study should prove useful in assessing the efficacy of dystrophin gene therapy in the mdx mouse.

Citing Articles

A conceptual model and practical guidance for the development, administration, and evaluation of individualized therapies.

Perillat L, McFadyen A, Furlong P, Anderson J Front Med (Lausanne). 2025; 12:1493832.

PMID: 39981075 PMC: 11841388. DOI: 10.3389/fmed.2025.1493832.


Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy.

Chwalenia K, Wood M, Roberts T J Muscle Res Cell Motil. 2025; .

PMID: 39883376 DOI: 10.1007/s10974-024-09688-2.


Impaired hydrogen sulfide biosynthesis underlies eccentric contraction-induced force loss in dystrophin-deficient skeletal muscle.

Southern W, Johnson E, Fasbender E, Fallon K, Cavazos C, Lowe D J Clin Invest. 2025; 135(5).

PMID: 39808494 PMC: 11870723. DOI: 10.1172/JCI176942.


Advanced Heart Failure Therapies in Neuromuscular Diseases.

Agdamag A, Nandar P, Tang W Curr Treat Options Cardiovasc Med. 2025; 26(8):255-270.

PMID: 39777119 PMC: 11706575. DOI: 10.1007/s11936-024-01046-2.


Reduced voltage-activated Ca2+ release flux in muscle fibers from a rat model of Duchenne dystrophy.

Schreiber J, Rotard L, Tourneur Y, Lafoux A, Berthier C, Allard B J Gen Physiol. 2024; 157(2).

PMID: 39718509 PMC: 11668172. DOI: 10.1085/jgp.202413588.


References
1.
Bradley W, Fulthorpe J . Studies of sarcolemmal integrity in myopathic muscle. Neurology. 1978; 28(7):670-7. DOI: 10.1212/wnl.28.7.670. View

2.
DiMarco A, Kelling J, DiMarco M, Jacobs I, Shields R, Altose M . The effects of inspiratory resistive training on respiratory muscle function in patients with muscular dystrophy. Muscle Nerve. 1985; 8(4):284-90. DOI: 10.1002/mus.880080404. View

3.
Ben Hamida M, Fardeau M, Attia N . Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia. Muscle Nerve. 1983; 6(7):469-80. DOI: 10.1002/mus.880060702. View

4.
Jones D, Jackson M, McPhail G, EDWARDS R . Experimental mouse muscle damage: the importance of external calcium. Clin Sci (Lond). 1984; 66(3):317-22. DOI: 10.1042/cs0660317. View

5.
McCully K, Faulkner J . Injury to skeletal muscle fibers of mice following lengthening contractions. J Appl Physiol (1985). 1985; 59(1):119-26. DOI: 10.1152/jappl.1985.59.1.119. View